ガストリン放出ペプチドのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Gastrin Releasing Peptide Market Insights, Forecast to 2028

• レポートコード：QY2207C3837 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、73ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のガストリン放出ペプチドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にガストリン放出ペプチドの世界市場のxxx％を占める「人間」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「科学研究」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のガストリン放出ペプチドの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのガストリン放出ペプチド市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのガストリン放出ペプチド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ガストリン放出ペプチドのグローバル主要メーカーには、R and D Systems、DiscoverX、Creative Biolabs、Peptide Instituteなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ガストリン放出ペプチド市場は、種類と用途によって区分されます。世界のガストリン放出ペプチド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 人間、豚、ネズミ 【用途別セグメント】 科学研究、医療、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ガストリン放出ペプチド製品概要 - 種類別市場（人間、豚、ネズミ） - 用途別市場（科学研究、医療、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のガストリン放出ペプチド販売量予測2017-2028 - 世界のガストリン放出ペプチド売上予測2017-2028 - ガストリン放出ペプチドの地域別販売量 - ガストリン放出ペプチドの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ガストリン放出ペプチド販売量 - 主要メーカー別ガストリン放出ペプチド売上 - 主要メーカー別ガストリン放出ペプチド価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（人間、豚、ネズミ） - ガストリン放出ペプチドの種類別販売量 - ガストリン放出ペプチドの種類別売上 - ガストリン放出ペプチドの種類別価格 ・用途別市場規模（科学研究、医療、その他） - ガストリン放出ペプチドの用途別販売量 - ガストリン放出ペプチドの用途別売上 - ガストリン放出ペプチドの用途別価格 ・北米市場 - 北米のガストリン放出ペプチド市場規模（種類別、用途別） - 主要国別のガストリン放出ペプチド市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのガストリン放出ペプチド市場規模（種類別、用途別） - 主要国別のガストリン放出ペプチド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のガストリン放出ペプチド市場規模（種類別、用途別） - 主要国別のガストリン放出ペプチド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のガストリン放出ペプチド市場規模（種類別、用途別） - 主要国別のガストリン放出ペプチド市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのガストリン放出ペプチド市場規模（種類別、用途別） - 主要国別のガストリン放出ペプチド市場規模（トルコ、サウジアラビア） ・企業情報 R and D Systems、DiscoverX、Creative Biolabs、Peptide Institute ・産業チェーン及び販売チャネル分析 - ガストリン放出ペプチドの産業チェーン分析 - ガストリン放出ペプチドの原材料 - ガストリン放出ペプチドの生産プロセス - ガストリン放出ペプチドの販売及びマーケティング - ガストリン放出ペプチドの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ガストリン放出ペプチドの産業動向 - ガストリン放出ペプチドのマーケットドライバー - ガストリン放出ペプチドの課題 - ガストリン放出ペプチドの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Gastrin Releasing Peptide Market
Due to the COVID-19 pandemic, the global Gastrin Releasing Peptide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Human accounting for % of the Gastrin Releasing Peptide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Scientific Research segment is altered to an % CAGR throughout this forecast period.
China Gastrin Releasing Peptide market size is valued at US$ million in 2021, while the US and Europe Gastrin Releasing Peptide are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Gastrin Releasing Peptide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Gastrin Releasing Peptide include R and D Systems, DiscoverX, Creative Biolabs and Peptide Institute, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Gastrin Releasing Peptide Scope and Segment
Gastrin Releasing Peptide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Gastrin Releasing Peptide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Human
Porcine
Rat and Mouse
Segment by Application
Scientific Research
Medical
Others
By Company
R and D Systems
DiscoverX
Creative Biolabs
Peptide Institute
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Gastrin Releasing Peptide Product Introduction
1.2 Market by Type
1.2.1 Global Gastrin Releasing Peptide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Human
1.2.3 Porcine
1.2.4 Rat and Mouse
1.3 Market by Application
1.3.1 Global Gastrin Releasing Peptide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gastrin Releasing Peptide Sales Estimates and Forecasts 2017-2028
2.2 Global Gastrin Releasing Peptide Revenue Estimates and Forecasts 2017-2028
2.3 Global Gastrin Releasing Peptide Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Gastrin Releasing Peptide Sales by Region
2.4.1 Global Gastrin Releasing Peptide Sales by Region (2017-2022)
2.4.2 Global Sales Gastrin Releasing Peptide by Region (2023-2028)
2.5 Global Gastrin Releasing Peptide Revenue by Region
2.5.1 Global Gastrin Releasing Peptide Revenue by Region (2017-2022)
2.5.2 Global Gastrin Releasing Peptide Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Gastrin Releasing Peptide Sales by Manufacturers
3.1.1 Global Top Gastrin Releasing Peptide Manufacturers by Sales (2017-2022)
3.1.2 Global Gastrin Releasing Peptide Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gastrin Releasing Peptide in 2021
3.2 Global Gastrin Releasing Peptide Revenue by Manufacturers
3.2.1 Global Gastrin Releasing Peptide Revenue by Manufacturers (2017-2022)
3.2.2 Global Gastrin Releasing Peptide Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Gastrin Releasing Peptide Revenue in 2021
3.3 Global Gastrin Releasing Peptide Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gastrin Releasing Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gastrin Releasing Peptide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gastrin Releasing Peptide Sales by Type
4.1.1 Global Gastrin Releasing Peptide Historical Sales by Type (2017-2022)
4.1.2 Global Gastrin Releasing Peptide Forecasted Sales by Type (2023-2028)
4.1.3 Global Gastrin Releasing Peptide Sales Market Share by Type (2017-2028)
4.2 Global Gastrin Releasing Peptide Revenue by Type
4.2.1 Global Gastrin Releasing Peptide Historical Revenue by Type (2017-2022)
4.2.2 Global Gastrin Releasing Peptide Forecasted Revenue by Type (2023-2028)
4.2.3 Global Gastrin Releasing Peptide Revenue Market Share by Type (2017-2028)
4.3 Global Gastrin Releasing Peptide Price by Type
4.3.1 Global Gastrin Releasing Peptide Price by Type (2017-2022)
4.3.2 Global Gastrin Releasing Peptide Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Gastrin Releasing Peptide Sales by Application
5.1.1 Global Gastrin Releasing Peptide Historical Sales by Application (2017-2022)
5.1.2 Global Gastrin Releasing Peptide Forecasted Sales by Application (2023-2028)
5.1.3 Global Gastrin Releasing Peptide Sales Market Share by Application (2017-2028)
5.2 Global Gastrin Releasing Peptide Revenue by Application
5.2.1 Global Gastrin Releasing Peptide Historical Revenue by Application (2017-2022)
5.2.2 Global Gastrin Releasing Peptide Forecasted Revenue by Application (2023-2028)
5.2.3 Global Gastrin Releasing Peptide Revenue Market Share by Application (2017-2028)
5.3 Global Gastrin Releasing Peptide Price by Application
5.3.1 Global Gastrin Releasing Peptide Price by Application (2017-2022)
5.3.2 Global Gastrin Releasing Peptide Price Forecast by Application (2023-2028)
6 North America
6.1 North America Gastrin Releasing Peptide Market Size by Type
6.1.1 North America Gastrin Releasing Peptide Sales by Type (2017-2028)
6.1.2 North America Gastrin Releasing Peptide Revenue by Type (2017-2028)
6.2 North America Gastrin Releasing Peptide Market Size by Application
6.2.1 North America Gastrin Releasing Peptide Sales by Application (2017-2028)
6.2.2 North America Gastrin Releasing Peptide Revenue by Application (2017-2028)
6.3 North America Gastrin Releasing Peptide Market Size by Country
6.3.1 North America Gastrin Releasing Peptide Sales by Country (2017-2028)
6.3.2 North America Gastrin Releasing Peptide Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Gastrin Releasing Peptide Market Size by Type
7.1.1 Europe Gastrin Releasing Peptide Sales by Type (2017-2028)
7.1.2 Europe Gastrin Releasing Peptide Revenue by Type (2017-2028)
7.2 Europe Gastrin Releasing Peptide Market Size by Application
7.2.1 Europe Gastrin Releasing Peptide Sales by Application (2017-2028)
7.2.2 Europe Gastrin Releasing Peptide Revenue by Application (2017-2028)
7.3 Europe Gastrin Releasing Peptide Market Size by Country
7.3.1 Europe Gastrin Releasing Peptide Sales by Country (2017-2028)
7.3.2 Europe Gastrin Releasing Peptide Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gastrin Releasing Peptide Market Size by Type
8.1.1 Asia Pacific Gastrin Releasing Peptide Sales by Type (2017-2028)
8.1.2 Asia Pacific Gastrin Releasing Peptide Revenue by Type (2017-2028)
8.2 Asia Pacific Gastrin Releasing Peptide Market Size by Application
8.2.1 Asia Pacific Gastrin Releasing Peptide Sales by Application (2017-2028)
8.2.2 Asia Pacific Gastrin Releasing Peptide Revenue by Application (2017-2028)
8.3 Asia Pacific Gastrin Releasing Peptide Market Size by Region
8.3.1 Asia Pacific Gastrin Releasing Peptide Sales by Region (2017-2028)
8.3.2 Asia Pacific Gastrin Releasing Peptide Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Gastrin Releasing Peptide Market Size by Type
9.1.1 Latin America Gastrin Releasing Peptide Sales by Type (2017-2028)
9.1.2 Latin America Gastrin Releasing Peptide Revenue by Type (2017-2028)
9.2 Latin America Gastrin Releasing Peptide Market Size by Application
9.2.1 Latin America Gastrin Releasing Peptide Sales by Application (2017-2028)
9.2.2 Latin America Gastrin Releasing Peptide Revenue by Application (2017-2028)
9.3 Latin America Gastrin Releasing Peptide Market Size by Country
9.3.1 Latin America Gastrin Releasing Peptide Sales by Country (2017-2028)
9.3.2 Latin America Gastrin Releasing Peptide Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gastrin Releasing Peptide Market Size by Type
10.1.1 Middle East and Africa Gastrin Releasing Peptide Sales by Type (2017-2028)
10.1.2 Middle East and Africa Gastrin Releasing Peptide Revenue by Type (2017-2028)
10.2 Middle East and Africa Gastrin Releasing Peptide Market Size by Application
10.2.1 Middle East and Africa Gastrin Releasing Peptide Sales by Application (2017-2028)
10.2.2 Middle East and Africa Gastrin Releasing Peptide Revenue by Application (2017-2028)
10.3 Middle East and Africa Gastrin Releasing Peptide Market Size by Country
10.3.1 Middle East and Africa Gastrin Releasing Peptide Sales by Country (2017-2028)
10.3.2 Middle East and Africa Gastrin Releasing Peptide Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 R and D Systems
11.1.1 R and D Systems Corporation Information
11.1.2 R and D Systems Overview
11.1.3 R and D Systems Gastrin Releasing Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 R and D Systems Gastrin Releasing Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 R and D Systems Recent Developments
11.2 DiscoverX
11.2.1 DiscoverX Corporation Information
11.2.2 DiscoverX Overview
11.2.3 DiscoverX Gastrin Releasing Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 DiscoverX Gastrin Releasing Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 DiscoverX Recent Developments
11.3 Creative Biolabs
11.3.1 Creative Biolabs Corporation Information
11.3.2 Creative Biolabs Overview
11.3.3 Creative Biolabs Gastrin Releasing Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Creative Biolabs Gastrin Releasing Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Creative Biolabs Recent Developments
11.4 Peptide Institute
11.4.1 Peptide Institute Corporation Information
11.4.2 Peptide Institute Overview
11.4.3 Peptide Institute Gastrin Releasing Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Peptide Institute Gastrin Releasing Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Peptide Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gastrin Releasing Peptide Industry Chain Analysis
12.2 Gastrin Releasing Peptide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gastrin Releasing Peptide Production Mode & Process
12.4 Gastrin Releasing Peptide Sales and Marketing
12.4.1 Gastrin Releasing Peptide Sales Channels
12.4.2 Gastrin Releasing Peptide Distributors
12.5 Gastrin Releasing Peptide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gastrin Releasing Peptide Industry Trends
13.2 Gastrin Releasing Peptide Market Drivers
13.3 Gastrin Releasing Peptide Market Challenges
13.4 Gastrin Releasing Peptide Market Restraints
14 Key Findings in The Global Gastrin Releasing Peptide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Gastrin Releasing Peptide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Human
Table 3. Major Manufacturers of Porcine
Table 4. Major Manufacturers of Rat and Mouse
Table 5. Global Gastrin Releasing Peptide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Gastrin Releasing Peptide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Gastrin Releasing Peptide Sales by Region (2017-2022) & (K Units)
Table 8. Global Gastrin Releasing Peptide Sales Market Share by Region (2017-2022)
Table 9. Global Gastrin Releasing Peptide Sales by Region (2023-2028) & (K Units)
Table 10. Global Gastrin Releasing Peptide Sales Market Share by Region (2023-2028)
Table 11. Global Gastrin Releasing Peptide Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Gastrin Releasing Peptide Revenue Market Share by Region (2017-2022)
Table 13. Global Gastrin Releasing Peptide Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Gastrin Releasing Peptide Revenue Market Share by Region (2023-2028)
Table 15. Global Gastrin Releasing Peptide Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Gastrin Releasing Peptide Sales Share by Manufacturers (2017-2022)
Table 17. Global Gastrin Releasing Peptide Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Gastrin Releasing Peptide Revenue Share by Manufacturers (2017-2022)
Table 19. Gastrin Releasing Peptide Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Gastrin Releasing Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Gastrin Releasing Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrin Releasing Peptide as of 2021)
Table 22. Gastrin Releasing Peptide Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Gastrin Releasing Peptide Product Offered
Table 24. Date of Manufacturers Enter into Gastrin Releasing Peptide Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gastrin Releasing Peptide Sales by Type (2017-2022) & (K Units)
Table 27. Global Gastrin Releasing Peptide Sales by Type (2023-2028) & (K Units)
Table 28. Global Gastrin Releasing Peptide Sales Share by Type (2017-2022)
Table 29. Global Gastrin Releasing Peptide Sales Share by Type (2023-2028)
Table 30. Global Gastrin Releasing Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Gastrin Releasing Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Gastrin Releasing Peptide Revenue Share by Type (2017-2022)
Table 33. Global Gastrin Releasing Peptide Revenue Share by Type (2023-2028)
Table 34. Gastrin Releasing Peptide Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Gastrin Releasing Peptide Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Gastrin Releasing Peptide Sales by Application (2017-2022) & (K Units)
Table 37. Global Gastrin Releasing Peptide Sales by Application (2023-2028) & (K Units)
Table 38. Global Gastrin Releasing Peptide Sales Share by Application (2017-2022)
Table 39. Global Gastrin Releasing Peptide Sales Share by Application (2023-2028)
Table 40. Global Gastrin Releasing Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Gastrin Releasing Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Gastrin Releasing Peptide Revenue Share by Application (2017-2022)
Table 43. Global Gastrin Releasing Peptide Revenue Share by Application (2023-2028)
Table 44. Gastrin Releasing Peptide Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Gastrin Releasing Peptide Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Gastrin Releasing Peptide Sales by Type (2017-2022) & (K Units)
Table 47. North America Gastrin Releasing Peptide Sales by Type (2023-2028) & (K Units)
Table 48. North America Gastrin Releasing Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Gastrin Releasing Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Gastrin Releasing Peptide Sales by Application (2017-2022) & (K Units)
Table 51. North America Gastrin Releasing Peptide Sales by Application (2023-2028) & (K Units)
Table 52. North America Gastrin Releasing Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Gastrin Releasing Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Gastrin Releasing Peptide Sales by Country (2017-2022) & (K Units)
Table 55. North America Gastrin Releasing Peptide Sales by Country (2023-2028) & (K Units)
Table 56. North America Gastrin Releasing Peptide Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Gastrin Releasing Peptide Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Gastrin Releasing Peptide Sales by Type (2017-2022) & (K Units)
Table 59. Europe Gastrin Releasing Peptide Sales by Type (2023-2028) & (K Units)
Table 60. Europe Gastrin Releasing Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Gastrin Releasing Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Gastrin Releasing Peptide Sales by Application (2017-2022) & (K Units)
Table 63. Europe Gastrin Releasing Peptide Sales by Application (2023-2028) & (K Units)
Table 64. Europe Gastrin Releasing Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Gastrin Releasing Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Gastrin Releasing Peptide Sales by Country (2017-2022) & (K Units)
Table 67. Europe Gastrin Releasing Peptide Sales by Country (2023-2028) & (K Units)
Table 68. Europe Gastrin Releasing Peptide Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Gastrin Releasing Peptide Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Gastrin Releasing Peptide Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Gastrin Releasing Peptide Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Gastrin Releasing Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Gastrin Releasing Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Gastrin Releasing Peptide Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Gastrin Releasing Peptide Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Gastrin Releasing Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Gastrin Releasing Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Gastrin Releasing Peptide Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Gastrin Releasing Peptide Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Gastrin Releasing Peptide Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Gastrin Releasing Peptide Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Gastrin Releasing Peptide Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Gastrin Releasing Peptide Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Gastrin Releasing Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Gastrin Releasing Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Gastrin Releasing Peptide Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Gastrin Releasing Peptide Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Gastrin Releasing Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Gastrin Releasing Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Gastrin Releasing Peptide Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Gastrin Releasing Peptide Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Gastrin Releasing Peptide Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Gastrin Releasing Peptide Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Gastrin Releasing Peptide Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Gastrin Releasing Peptide Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Gastrin Releasing Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Gastrin Releasing Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Gastrin Releasing Peptide Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Gastrin Releasing Peptide Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Gastrin Releasing Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Gastrin Releasing Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Gastrin Releasing Peptide Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Gastrin Releasing Peptide Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Gastrin Releasing Peptide Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Gastrin Releasing Peptide Revenue by Country (2023-2028) & (US$ Million)
Table 106. R and D Systems Corporation Information
Table 107. R and D Systems Description and Major Businesses
Table 108. R and D Systems Gastrin Releasing Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. R and D Systems Gastrin Releasing Peptide Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. R and D Systems Recent Developments
Table 111. DiscoverX Corporation Information
Table 112. DiscoverX Description and Major Businesses
Table 113. DiscoverX Gastrin Releasing Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. DiscoverX Gastrin Releasing Peptide Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. DiscoverX Recent Developments
Table 116. Creative Biolabs Corporation Information
Table 117. Creative Biolabs Description and Major Businesses
Table 118. Creative Biolabs Gastrin Releasing Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Creative Biolabs Gastrin Releasing Peptide Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Creative Biolabs Recent Developments
Table 121. Peptide Institute Corporation Information
Table 122. Peptide Institute Description and Major Businesses
Table 123. Peptide Institute Gastrin Releasing Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Peptide Institute Gastrin Releasing Peptide Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Peptide Institute Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Gastrin Releasing Peptide Distributors List
Table 129. Gastrin Releasing Peptide Customers List
Table 130. Gastrin Releasing Peptide Market Trends
Table 131. Gastrin Releasing Peptide Market Drivers
Table 132. Gastrin Releasing Peptide Market Challenges
Table 133. Gastrin Releasing Peptide Market Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrin Releasing Peptide Product Picture
Figure 3. Global Gastrin Releasing Peptide Market Share by Type in 2021 & 2028
Figure 3. Human Product Picture
Figure 4. Porcine Product Picture
Figure 5. Rat and Mouse Product Picture
Figure 6. Global Gastrin Releasing Peptide Market Share by Application in 2021 & 2028
Figure 7. Scientific Research
Figure 8. Medical
Figure 9. Others
Figure 10. Gastrin Releasing Peptide Report Years Considered
Figure 11. Global Gastrin Releasing Peptide Sales 2017-2028 (K Units)
Figure 12. Global Gastrin Releasing Peptide Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Gastrin Releasing Peptide Revenue 2017-2028 (US$ Million)
Figure 14. Global Gastrin Releasing Peptide Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Gastrin Releasing Peptide Sales Market Share by Region (2017-2022)
Figure 16. Global Gastrin Releasing Peptide Sales Market Share by Region (2023-2028)
Figure 17. North America Gastrin Releasing Peptide Sales YoY (2017-2028) & (K Units)
Figure 18. North America Gastrin Releasing Peptide Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Gastrin Releasing Peptide Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Gastrin Releasing Peptide Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Gastrin Releasing Peptide Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Gastrin Releasing Peptide Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Gastrin Releasing Peptide Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Gastrin Releasing Peptide Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Gastrin Releasing Peptide Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Gastrin Releasing Peptide Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Gastrin Releasing Peptide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Gastrin Releasing Peptide in the World: Market Share by Gastrin Releasing Peptide Revenue in 2021
Figure 29. Global Gastrin Releasing Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Gastrin Releasing Peptide Sales Market Share by Type (2017-2028)
Figure 31. Global Gastrin Releasing Peptide Revenue Market Share by Type (2017-2028)
Figure 32. Global Gastrin Releasing Peptide Sales Market Share by Application (2017-2028)
Figure 33. Global Gastrin Releasing Peptide Revenue Market Share by Application (2017-2028)
Figure 34. North America Gastrin Releasing Peptide Sales Market Share by Type (2017-2028)
Figure 35. North America Gastrin Releasing Peptide Revenue Market Share by Type (2017-2028)
Figure 36. North America Gastrin Releasing Peptide Sales Market Share by Application (2017-2028)
Figure 37. North America Gastrin Releasing Peptide Revenue Market Share by Application (2017-2028)
Figure 38. North America Gastrin Releasing Peptide Sales Share by Country (2017-2028)
Figure 39. North America Gastrin Releasing Peptide Revenue Share by Country (2017-2028)
Figure 40. United States Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Gastrin Releasing Peptide Sales Market Share by Type (2017-2028)
Figure 43. Europe Gastrin Releasing Peptide Revenue Market Share by Type (2017-2028)
Figure 44. Europe Gastrin Releasing Peptide Sales Market Share by Application (2017-2028)
Figure 45. Europe Gastrin Releasing Peptide Revenue Market Share by Application (2017-2028)
Figure 46. Europe Gastrin Releasing Peptide Sales Share by Country (2017-2028)
Figure 47. Europe Gastrin Releasing Peptide Revenue Share by Country (2017-2028)
Figure 48. Germany Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 49. France Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Gastrin Releasing Peptide Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Gastrin Releasing Peptide Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Gastrin Releasing Peptide Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Gastrin Releasing Peptide Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Gastrin Releasing Peptide Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Gastrin Releasing Peptide Revenue Share by Region (2017-2028)
Figure 59. China Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 62. India Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Gastrin Releasing Peptide Sales Market Share by Type (2017-2028)
Figure 69. Latin America Gastrin Releasing Peptide Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Gastrin Releasing Peptide Sales Market Share by Application (2017-2028)
Figure 71. Latin America Gastrin Releasing Peptide Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Gastrin Releasing Peptide Sales Share by Country (2017-2028)
Figure 73. Latin America Gastrin Releasing Peptide Revenue Share by Country (2017-2028)
Figure 74. Mexico Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Gastrin Releasing Peptide Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Gastrin Releasing Peptide Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Gastrin Releasing Peptide Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Gastrin Releasing Peptide Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Gastrin Releasing Peptide Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Gastrin Releasing Peptide Revenue Share by Country (2017-2028)
Figure 83. Turkey Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Gastrin Releasing Peptide Revenue (2017-2028) & (US$ Million)
Figure 86. Gastrin Releasing Peptide Value Chain
Figure 87. Gastrin Releasing Peptide Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---